Thrombinogen time reduced from (35.18±9.26)% before the treatment to (19.61±10.26) % after the treatment, and bleeding tendency was corrected.
血浆白蛋白﹑转氨酶﹑肾功能较前好转,凝血酶原时间由治疗前(35.18±9.26)%下降(19.61±10.26)%出血倾向得到纠正。
Thrombinogen time reduced from (35.18±9.26)% before the treatment to (19.61±10.26) % after the treatment, and bleeding tendency was corrected.
血浆白蛋白﹑转氨酶﹑肾功能较前好转,凝血酶原时间由治疗前(35.18±9.26)%下降(19.61±10.26)%出血倾向得到纠正。
声明:以上、词性类均由互联网资源自动生,未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。